Eicosapentanoic acid prolongs survival and attenuates inflammatory response in an experimental model of lethal trauma

Prostaglandins Leukot Essent Fatty Acids. 2010 Aug;83(2):69-74. doi: 10.1016/j.plefa.2010.05.001. Epub 2010 Jun 9.

Abstract

In an attempt to define the efficacy of intravenously administered n-3 polyunsaturated fatty acids (PUFAs) in an animal model of lethal trauma following femur fracture, an intravenous solution of eicosapentanoic acid (EPA) - one n-3 PUFA - was administered in 25 rabbits; 13 were controls and 12 were treated with EPA 30 min after fracture. Vital signs were recorded and serum concentrations of tumor necrosis factor-alpha (TNFalpha) and respiratory burst of neutrophils were assessed. Survival of controls was 7.7% and of animals treated with EPA 50% (log-rank: 5.162; p: 0.023). Vital signs of both groups did not differ. Oxidative burst of neutrophils was greater among EPA-treated animals compared with controls at 48 h (p: 0.010). Serum levels of TNFalpha of the former group were decreased compared with the latter at 48 h (p: 0.019). Bacterial growth of enterobacteriaceae from liver and spleen after death or euthanasia was lower among EPA-treated rabbits than controls. These results suggest that EPA possesses considerable immunomodulatory activities improving survival in a model of lethal trauma. Restoration of oxidative burst conferring efficient phagocytosis of evading bacteria seems the most probable mechanism of action.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Eicosapentaenoic Acid / pharmacology*
  • Enterobacteriaceae / growth & development
  • Femoral Fractures / blood*
  • Femoral Fractures / drug therapy*
  • Femoral Fractures / microbiology
  • Humans
  • Inflammation / blood
  • Inflammation / drug therapy
  • Inflammation Mediators / blood*
  • Liver / metabolism
  • Liver / microbiology
  • Male
  • Neutrophils / metabolism
  • Phagocytosis / drug effects
  • Rabbits
  • Respiratory Burst / drug effects
  • Spleen / metabolism
  • Spleen / microbiology
  • Tumor Necrosis Factor-alpha / blood*

Substances

  • Inflammation Mediators
  • Tumor Necrosis Factor-alpha
  • Eicosapentaenoic Acid